Aikenist Secures Seed Funding Round
Aikenist, a Bengaluru, India-based gen-AI-powered smart workflow solutions provider, has secured seed funding round.
Aikenist, a Bengaluru, India-based gen-AI-powered smart workflow solutions provider, has secured seed funding round.
Investors
The round was led by Venture Catalysts, with participation from MARL Fund, Quant Fund, C-CAMP, Nandak Growth Catalysts, and several angel investors.
Venture Catalysts, founded in 2016 and based in Mumbai, Maharashtra, India, is a venture capital firm that focuses on investments in the Internet of Things, software, and digital health sectors.
Aikenist Use of Funds
The newly raised funds will accelerate Aikenist's growth in AI-driven MRI solutions, enhancing its offerings and expanding its market presence.
About Aikenist
Aikenist is a healthcare technology company that provides gen-AI-based smart workflow solutions, particularly for the medical imaging and radiology sectors. Founded by Ashwin Amarapur, the company focuses on leveraging artificial intelligence to optimize and expedite magnetic resonance imaging (MRI) processes for diagnostic centers and hospitals. Its flagship product, QuickSuite, optimizes end-to-end radiology workflows, including scan acquisition, analysis, and reporting. Aikenist's mission is to make medical imaging faster, more affordable, and more effective.
Funding Details
Company: Aikenist.com Technologies Private Limited
Raised: Undisclosed
Round: Seed Round
Funding Date: October 2024
Lead Investor: Venture Catalysts
Additional Investors: MARL Fund, Quant Fund, C-CAMP, Nandak Growth Catalysts
Company Website: https://www.aikenist.com/
Software Category: Workflow Solutions
